Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary E Gallick

Showing results (21-30 of 114) with videos related to

Pageof 12
Sort By:
Pancreas|September 16, 2005
c-Src regulates constitutive and EGF-mediated VEGF expression in pancreatic tumor cells through activation of phosphatidyl inositol-3 kinase and p38 MAPKJustin M Summy, Jose G Trevino, Cheryl H Baker, et al.
Cancer Metastasis Reviews|February 14, 2014
Src signaling pathways in prostate cancerAndreas Varkaris, Anastasia D Katsiampoura, John C Araujo, et al.
Cell Discovery|July 28, 2016
ALG-2 activates the MVB sorting function of ALIX through relieving its intramolecular interactionSheng Sun, Xi Zhou, Joe Corvera, et al.
Cell Discovery|July 28, 2016
Erratum: ALG-2 activates the MVB sorting function of ALIX through relieving its intramolecular interactionSheng Sun, Xi Zhou, Joe Corvera, et al.
Plos One|August 5, 2009
GWAS meets microarray: are the results of genome-wide association studies and gene-expression profiling consistent? Prostate cancer as an exampleIvan P Gorlov, Gary E Gallick, Olga Y Gorlova, et al.
The American Journal of Pathology|January 28, 2003
A urokinase-derived peptide (A6) increases survival of mice bearing orthotopically grown prostate cancer and reduces lymph node metastasisDouglas D Boyd, Sun-Jin Kim, Heng Wang, et al.
Expert Opinion on Investigational Drugs|November 1, 2011
The role of HGF/c-Met signaling in prostate cancer progression and c-Met inhibitors in clinical trialsAndreas Varkaris, Paul G Corn, Sanchaika Gaur, et al.
Molecular Carcinogenesis|October 15, 2010
Loss of tyrosine phosphatase-dependent inhibition promotes activation of tyrosine kinase c-Src in detached pancreatic cellsSarah F Connelly, Beth A Isley, Cheryl H Baker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Reduced c-Met expression by an adenovirus expressing a c-Met ribozyme inhibits tumorigenic growth and lymph node metastases of PC3-LN4 prostate tumor cells in an orthotopic nude mouse modelSun Jin Kim, Marjorie Johnson, Kristen Koterba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
Molecular mechanisms of resistance to therapies targeting the epidermal growth factor receptorE Ramsay Camp, Justin Summy, Todd W Bauer, et al.
Pageof 12

Showing results (21-30 of 114) with videos related to

Sort By:
Pageof 12
Pancreas|September 16, 2005
c-Src regulates constitutive and EGF-mediated VEGF expression in pancreatic tumor cells through activation of phosphatidyl inositol-3 kinase and p38 MAPKJustin M Summy, Jose G Trevino, Cheryl H Baker, et al.
Cancer Metastasis Reviews|February 14, 2014
Src signaling pathways in prostate cancerAndreas Varkaris, Anastasia D Katsiampoura, John C Araujo, et al.
Cell Discovery|July 28, 2016
ALG-2 activates the MVB sorting function of ALIX through relieving its intramolecular interactionSheng Sun, Xi Zhou, Joe Corvera, et al.
Cell Discovery|July 28, 2016
Erratum: ALG-2 activates the MVB sorting function of ALIX through relieving its intramolecular interactionSheng Sun, Xi Zhou, Joe Corvera, et al.
Plos One|August 5, 2009
GWAS meets microarray: are the results of genome-wide association studies and gene-expression profiling consistent? Prostate cancer as an exampleIvan P Gorlov, Gary E Gallick, Olga Y Gorlova, et al.
The American Journal of Pathology|January 28, 2003
A urokinase-derived peptide (A6) increases survival of mice bearing orthotopically grown prostate cancer and reduces lymph node metastasisDouglas D Boyd, Sun-Jin Kim, Heng Wang, et al.
Expert Opinion on Investigational Drugs|November 1, 2011
The role of HGF/c-Met signaling in prostate cancer progression and c-Met inhibitors in clinical trialsAndreas Varkaris, Paul G Corn, Sanchaika Gaur, et al.
Molecular Carcinogenesis|October 15, 2010
Loss of tyrosine phosphatase-dependent inhibition promotes activation of tyrosine kinase c-Src in detached pancreatic cellsSarah F Connelly, Beth A Isley, Cheryl H Baker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Reduced c-Met expression by an adenovirus expressing a c-Met ribozyme inhibits tumorigenic growth and lymph node metastases of PC3-LN4 prostate tumor cells in an orthotopic nude mouse modelSun Jin Kim, Marjorie Johnson, Kristen Koterba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
Molecular mechanisms of resistance to therapies targeting the epidermal growth factor receptorE Ramsay Camp, Justin Summy, Todd W Bauer, et al.
Pageof 12